MELISSA HORN: Open Payments
NPI 1215411145 · BIRMINGHAM, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$988 in 49 payments from 9 companies in 2025. Trend: 2023 $1,812 · 2024 $1,285 · 2025 $988
Food & beverage: $988
| Company | Payments | Amount |
|---|---|---|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 30 | $295 |
| Boston Scientific Corporation | 5 | $177 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $135 |
| Actelion Pharmaceuticals US, Inc. | 1 | $133 |
| Stryker Corporation | 4 | $101 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $53 |
| E.R. Squibb & Sons, L.L.C. | 2 | $38 |
| Amgen Inc. | 1 | $29 |
| Abbott Laboratories | 1 | $28 |
Products named: LifeVest, ENROUTE Transcarotid Neuroprotection System, Kerendia, UPTRAVI, FLOWTRIEVER, JARDIANCE, ARTIX MT, REPATHA.
Industry payments across AL — which companies pay providers there.
